240 related articles for article (PubMed ID: 27680294)
1. Detection of Local Tumor Recurrence After Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Histogram Analysis of Dynamic Contrast-Enhanced T1-Weighted Perfusion MRI.
Choi SH; Lee JH; Choi YJ; Park JE; Sung YS; Kim N; Baek JH
AJR Am J Roentgenol; 2017 Jan; 208(1):42-47. PubMed ID: 27680294
[TBL] [Abstract][Full Text] [Related]
2. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
[TBL] [Abstract][Full Text] [Related]
3. Detection of Local Recurrence in Patients with Head and Neck Squamous Cell Carcinoma Using Voxel-Based Color Maps of Initial and Final Area under the Curve Values Derived from DCE-MRI.
Lee JY; Cheng KL; Lee JH; Choi YJ; Kim HW; Sung YS; Chung SR; Ryu KH; Chung MS; Kim SY; Lee SW; Baek JH
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1392-1401. PubMed ID: 31320461
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.
Hwang I; Choi SH; Kim YJ; Kim KG; Lee AL; Yun TJ; Kim JH; Sohn CH
AJNR Am J Neuroradiol; 2013 Dec; 34(12):2343-8. PubMed ID: 23811978
[TBL] [Abstract][Full Text] [Related]
5. Advanced diffusion models in head and neck squamous cell carcinoma patients: Goodness of fit, relationships among diffusion parameters and comparison with dynamic contrast-enhanced perfusion.
Fujima N; Sakashita T; Homma A; Shimizu Y; Yoshida A; Harada T; Tha KK; Kudo K; Shirato H
Magn Reson Imaging; 2017 Feb; 36():16-23. PubMed ID: 27989906
[TBL] [Abstract][Full Text] [Related]
6. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
[TBL] [Abstract][Full Text] [Related]
7. MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter.
Ailianou A; Mundada P; De Perrot T; Pusztaszieri M; Poletti PA; Becker M
AJNR Am J Neuroradiol; 2018 Apr; 39(4):748-755. PubMed ID: 29449279
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
[TBL] [Abstract][Full Text] [Related]
9. Histogram analysis of apparent diffusion coefficient maps in the prognosis of patients with locally advanced head and neck squamous cell carcinoma: Comparison of different region of interest selection methods.
Ren JL; Yuan Y; Li XX; Shi YQ; Tao XF
Eur J Radiol; 2018 Sep; 106():7-13. PubMed ID: 30150054
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.
Suh CH; Kim HS; Choi YJ; Kim N; Kim SJ
AJNR Am J Neuroradiol; 2013 Dec; 34(12):2278-86. PubMed ID: 23828115
[TBL] [Abstract][Full Text] [Related]
11. Correlation study between intravoxel incoherent motion MRI and dynamic contrast-enhanced MRI in head and neck squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes.
Marzi S; Piludu F; Forina C; Sanguineti G; Covello R; Spriano G; Vidiri A
Magn Reson Imaging; 2017 Apr; 37():1-8. PubMed ID: 27742432
[TBL] [Abstract][Full Text] [Related]
12. Measurement of tumor blood flow in head and neck squamous cell carcinoma by pseudo-continuous arterial spin labeling: comparison with dynamic contrast-enhanced MRI.
Fujima N; Kudo K; Tsukahara A; Yoshida D; Sakashita T; Homma A; Tha KK; Shirato H
J Magn Reson Imaging; 2015 Apr; 41(4):983-91. PubMed ID: 25787123
[TBL] [Abstract][Full Text] [Related]
13. Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.
Chung WJ; Kim HS; Kim N; Choi CG; Kim SJ
Radiology; 2013 Nov; 269(2):561-8. PubMed ID: 23878286
[TBL] [Abstract][Full Text] [Related]
14. Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion.
Tsuchiya N; Doai M; Usuda K; Uramoto H; Tonami H
PLoS One; 2017; 12(2):e0172433. PubMed ID: 28207858
[TBL] [Abstract][Full Text] [Related]
15. Intravoxel Incoherent Motion MR Imaging in the Head and Neck: Correlation with Dynamic Contrast-Enhanced MR Imaging and Diffusion-Weighted Imaging.
Xu XQ; Choi YJ; Sung YS; Yoon RG; Jang SW; Park JE; Heo YJ; Baek JH; Lee JH
Korean J Radiol; 2016; 17(5):641-9. PubMed ID: 27587952
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Model Using Radiomics Features from an Apparent Diffusion Coefficient Map to Diagnose Local Tumor Recurrence in Patients Treated for Head and Neck Squamous Cell Carcinoma.
Kim M; Lee JH; Joo L; Jeong B; Kim S; Ham S; Yun J; Kim N; Chung SR; Choi YJ; Baek JH; Lee JY; Kim JH
Korean J Radiol; 2022 Nov; 23(11):1078-1088. PubMed ID: 36126954
[TBL] [Abstract][Full Text] [Related]
17. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
[TBL] [Abstract][Full Text] [Related]
18. Prediction of pathological complete response in locally advanced head and neck squamous cell carcinoma treated with neoadjuvant chemo-immunotherapy using volumetric multisequence MRI histogram analysis.
Liu H; Zhu C; Wang X; Chen X; Li Z; Xian J
Neuroradiology; 2024 Jun; 66(6):919-929. PubMed ID: 38503986
[TBL] [Abstract][Full Text] [Related]
19. Perfusion CT of head and neck cancer.
Razek AA; Tawfik AM; Elsorogy LG; Soliman NY
Eur J Radiol; 2014 Mar; 83(3):537-44. PubMed ID: 24387935
[TBL] [Abstract][Full Text] [Related]
20. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
